BerandaAIMI • OTCMKTS
add
AIM ImmunoTech Inc
Tutup sebelumnya
$0,079
Rentang hari
$0,073 - $0,085
Rentang tahun
$0,025 - $0,36
Kapitalisasi pasar
6,05Â jt USD
Volume Rata-Rata
489,46Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
OTCMKTS
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 45,00Â rb | -30,77% |
Biaya operasional | 5,89Â jt | -58,08% |
Laba bersih | -5,97Â jt | 52,55% |
Margin laba bersih | -13,26Â rb | 31,46% |
Penghasilan per saham | -0,10 | 64,56% |
EBITDA | -5,79Â jt | 58,48% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,98Â jt | -69,57% |
Total aset | 8,61Â jt | -55,59% |
Total liabilitas | 9,93Â jt | 8,56% |
Total ekuitas | -1,32 jt | — |
Saham yang beredar | 72,29 jt | — |
Harga terhadap nilai buku | -3,94 | — |
Tingkat pengembalian aset | -131,89% | — |
Tingkat pengembalian modal | -369,07% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -5,97Â jt | 52,55% |
Kas dari operasi | -3,96Â jt | 59,47% |
Kas dari investasi | 3,70Â jt | 1.830,84% |
Kas dari pembiayaan | 1,04Â jt | 605,44% |
Perubahan kas bersih | 786,00Â rb | 108,00% |
Arus kas bebas | -3,65Â jt | 40,05% |
Tentang
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Didirikan
1966
Kantor pusat
Situs
Karyawan
22
